Press "Enter" to skip to content

Month: September 2025

Pfizer to lower prescription drug costs for Medicaid in a deal with Trump

WASHINGTON, United States — Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday, as he promised similar deals with other drugmakers under the threat of tariffs. Trump made the announcement at the White House alongside Pfizer CEO Albert Bourla

What is lecanemab, the newly approved Alzheimer’s drug? Can it really slow down dementia

Dementia is a condition that results in progressive memory or thinking problems. It’s now the most common cause of death in Australia. There are many different causes of dementia, but Alzheimer’s disease accounts for about 60%80% of all cases. Last week, Australia’s Therapeutic Goods Administration (TGA) approved a new drug for early Alzheimer’s diseases: lecanemab, [.] The post What is lecanemab, the newly approved Alzheimer’s drug? Can it really slow down dementia appeared first on Knowridge Science Report.